OTC Herbal and Traditional Medicines Market
OTC Herbal and Traditional Medicines Market By Function (OTC Herbal and Traditional Medicines for Immune Health, Digestive Health, Heart Health, Nutrition, Bone & Joint Health & Weight Loss), By OTC Channel, By Dosage - Global Market Insights 2021 to 2031
Analysis of OTC Herbal and Traditional Medicines market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
FREE CustomizationOTC Herbal and Traditional Medicines Market Outlook
Skilled analysts at Fact.MR, a market research and competitive intelligence provider, has recently released a revised analysis on the global OTC herbal and traditional medicines market, which is slated to rise at a CAGR of 4% over the decade.
| Report Attributes | Details |
|---|---|
| Global Market Value in 2020 | US$ 160 Bn |
| Market Value Forecasted for 2031 | US$ 240 Bn |
| CAGR (2021 to 2031) | 4% |
| Dominant Market | APAC |
The market was worth around US$ 160 billion in 2020 and is predicted to rise by nearly US$ 240 billion by the end of 2031.
Demand Analysis of OTC Herbal and Traditional Medicines (2016 to 2020) Vs Market Forecasts (2021 to 2031)
In the past decade, the world has seen a substantial rise in the prevalence of diseases and outbreaks of various viruses. The long term effects of synthetic drugs have also been extensively researched as people have faced problems regarding them. This has led to an increase in research into alternative healthcare like herbal and traditional medicines.
Consumers are now more aware of what they consume and this has been a major factor in propelling the demand for OTC traditional medicines. The adoption of traditional and herbal medicines is on the rise and is expected to be substantially higher by the end of the decade. The top manufacturers of OTC herbal and traditional medicines are focusing on developing naturally derived OTC medicines owing to the increase in demand from consumers.
OTC herbal and traditional medicines market growth through 2031 is predicted to evolve at a CAGR of 4%.
On the basis of Application, How is the Market Classified?
OTC herbal and traditional medicines can be classified as per their applications in the healthcare infrastructure. The additional segmentation can be given as:
- Application of OTC Herbal and Traditional Medicines as Detoxification Medicines
- Application of OTC Herbal and Traditional Medicines as Antipyretic Medicines
- Application of OTC Herbal and Traditional Medicines as Digestive Medicines
- Application of OTC Herbal and Traditional Medicines as Blood Circulation Medicines
These various applications are expected to increase in demand as manufacturers advance their research and expand their product portfolios. The demand for OTC herbal and traditional medicine in detoxification is expected to be driven by the trends of healthy lifestyle and organic eating. Trend of shifting towards more nature-based and organic products is also expected to propel the demand for OTC botanical medicine and to some extent even the sales of OTC phytomedicine.
How is Demand for OTC Herbal and Traditional Medicines Shaping Up on the Basis of Function?
The research categorizes the market on the basis of functionality, and this is one of the most prominent aspects for the evaluation of the market.
Sales of OTC herbal and traditional medicines for digestive health are expected to account for the largest revenue share in this segment. The sales of OTC herbal and traditional medicines for nutrition are expected to follow and be second-largest in terms of revenue. While the sales of OTC herbal and traditional medicines for bone & joint health are expected to rise at a similar CAGR to that for nutrition their revenues are expected to be substantially lesser than that of nutrition segment.
Demand for OTC herbal and traditional medicines for general well-being and the demand for OTC herbal and traditional medicines for heart health are expected to see a steady rise over the next ten years as research for these functions increases and more products are launched.
Use of OTC herbal and traditional medicines for weight loss is predicted to be significantly prominent in the global industry as research in this domain progresses.
How are Sales of OTC Herbal Medicines Progressing?
Sales of OTC herbal and traditional medicine are expected to see a rise over the next ten years and among all the sales channels modern trade is expected to be the most significant. Followed by sales via online channels, which were extremely high in the COVID-19 pandemic era and are expected to follow a healthy rise through the forecast period.
Sales via pharmacy channel are expected to rise at a relatively slower CAGR but are anticipated to pick up by the end of the decade. The over-the-counter herbal and traditional medicines market is anticipated to see some major shifts in sales trends via different channels over the decade.
Which Regions Majorly Influence OTC Herbal and Traditional Medicines Market Growth?
This research details the global OTC herbal and traditional medicine landscape across regions such as North America, Latin America, Europe, APAC, and MEA.
APAC dominated the market in terms of market share in 2020. The region is expected to continue its dominance throughout the forecast period due to presence of prominent players and increasing demand and research from nations like India.
North America is anticipated to be the second largest market for OTC herbal and traditional medicine and is expected to evolve at a good CAGR over the decade as awareness for herbal and traditional medicine increases. The market in Europe is also expected to evolve at a steady pace. The market in the MEA region has a lot of untapped potential which is expected to come into play over the next ten years.
Country-wise Analysis
Will the U.S. Herbal and Traditional Medicines Market Be Profitable for Industry Players?
The U.S. has been seeing some major shift in alternative medicine industry as the population is shying away from the synthetic drugs and medicines which have been discovered to have side effects. The rising demand from aware consumers for more natural and organic products and medicines is majorly driving demand for OTC herbal and traditional medicines in the U.S. The market players can cash in on this potential if they can provide what the end-users are looking for.
How Important is India in the Global OTC Herbal and Traditional Medicines Space?
Traditional and herbal systems of medicines have been popular in India from a long time as people in the nation have been using them over decades dating back to hundreds of years. Ayurveda, Unani are some of the prominent areas being researched in India and they will be an important export to the world as India is a leading name in these fields of traditional and herbal medicines.
Top manufacturers of OTC herbal medicines are based in India and the research and developments in India by them are crucial to the global market expansion.
Category-wise Analysis
What is the Outlook for Powder Dosage of OTC Herbal and Traditional Medicines?
Sales of OTC powdered herbal and traditional medicine are expected to account for majority of revenue share in the dosage segment. The demand for OTC herbal and traditional medicine tablet and demand for OTC liquid herbal and traditional medicines are expected to evolve at a similar CAGR while tablet dosage would account for more revenue share than the liquid dosage segment.
Competitive Landscape
Manufacturers are investing in research & development of new products to capture market potential as per consumer demand. New product launches and increase in research are expected to be prominent trends.
- In Tanzania’s Zanzibar, a research project funded by Tanzania Commission for Science and Technology, was launched in early October 2021 which is aimed at researching the use of herbal medicines for non-communicable diseases and their utilization as an alternative treatment method. The research will be carried out by researchers at Zanzibar Health Research Institute and the National Institute for Medical Research.
- Gingko Bioworks has launched a new venture by the name of Ayana Bio which is aimed at producing plant and fungal bioactives for herbal medicines. The Ayana Bio has been launched in September 2021 with a series A funding from Viking Global Investors and Cascade Investment.
- On June 30th 2021, Maharishi Ayurveda announced the launch of its new product to treat sleep disorders. The product is completely herbal and produces a calming and balancing effect and body and mind as well. The product has been launched when sleep disorders like insomnia are on the rise.
OTC Herbal and Traditional Medicine Industry Report Scope
| Report Attributes | Details |
|---|---|
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | Units for Sales US$ Million for Value |
| Key Regions Covered | North America; Latin America; Europe; APEJ; MEA |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, U.K., France, Spain, Italy, China, Japan, South Korea, India, Indonesia, Malaysia, Singapore, Australia, New Zealand, Turkey, South Africa, and GCC Countries |
| Key Market Segments Covered | Function, OTC Channel, Dosage, Region |
| Key Companies Profiled | Amway Corporation; Herbalife International; The Himalayan Drug Company; Naturex SA; Blackmores Limited; Nutraceutical International Corporation; The Nature's Bounty Co.; Bio-Botanica Inc.; The Bioforce Group; Ricola AG. |
| Pricing | Available upon Request |
Key Segments of OTC Herbal and Traditional Medicines Industry Survey
-
By Function:
- OTC Herbal and Traditional Medicines for Immune Health
- OTC Herbal and Traditional Medicines for Digestive Health
- OTC Herbal and Traditional Medicines for Heart Health
- OTC Herbal and Traditional Medicines for Nutrition
- OTC Herbal and Traditional Medicines for Bone & Joint Health
- OTC Herbal and Traditional Medicines for General Well-being
- OTC Herbal and Traditional Medicines for Weight Loss
- Other Functions
-
By OTC Channel:
- Sales of OTC Herbal and Traditional Medicines via Pharmacies
- Drug Store Sales of OTC Herbal and Traditional Medicines
- Modern Trade Sales of OTC Herbal and Traditional Medicines
- Online Sales of OTC Herbal and Traditional Medicines
- Other OTC Formats
-
By Dosage:
- Liquid OTC Herbal and Traditional Medicines
- Capsule OTC Herbal and Traditional Medicines
- Tablet OTC Herbal and Traditional Medicines
- Powder OTC Herbal and Traditional Medicines
Table of Content
- 1. Global Market to Executive Summary
- 2. Global Market Overview
- 3. Global Market Analysis and Forecast By Function
- 3.1. Immune Health
- 3.2. Digestive Health
- 3.3. Heart Health
- 3.4. Nutrition
- 3.5. Bone & Joint Health OTC Herbal and Traditional
- 3.6. General Well-being OTC Herbal and Traditional
- 3.7. Weight Loss OTC Herbal and Traditional
- 3.8. Other Functions OTC Herbal and Traditional
- 4. Global Market Analysis and Forecast By OTC Channel
- 4.1. Pharmacy
- 4.2. Drug Store
- 4.3. Modern Trade
- 4.4. Online
- 4.5. Other OTC Format OTC Herbal and Traditional
- 5. Global Market Analysis and Forecast By Dosage
- 5.1. Liquid
- 5.2. Capsule
- 5.3. Tablet
- 5.4. Powder
- 6. Global Market Analysis and Forecast By Region
- 6.1. North America
- 6.2. Latin America
- 6.3. Europe
- 6.4. Japan
- 6.5. APEJ
- 6.6. MEA
- 7. North America Market Analysis and Forecast, By Country, 2016 to 2031
- 8. Latin America Market Analysis and Forecast, By Country, 2016 to 2031
- 9. Europe Market Analysis and Forecast, By Country, 2016 to 2031
- 10. Japan Market Analysis and Forecast, By Country, 2016 to 2031
- 11. APEJ Market Analysis and Forecast, By Country, 2016 to 2031
- 12. MEA Market Analysis and Forecast, By Country, 2016 to 2031
- 13. Global Market Company/Manufacturers/Distributors/Suppliers Profile and Revenue Projections
- 13.1. Company Share Analysis
- 13.2. Amway Corporation
- 13.3. Herbalife International
- 13.4. The Himalayan Drug Company
- 13.5. Naturex SA
- 13.6. Blackmores Limited
- 13.7. Nutraceutical International Corporation
- 13.8. The Nature's Bounty Co.
- 13.9. Bio Botanica, Inc.
- 13.10. The Bioforce Group
- 13.11. Ricola AG
- 13.12. Bionorica SE
- 13.13. Integria Healthcare Pty Ltd.
- 13.14. Jiaherb Inc.
- 13.15. Nutra Green Biotechnology Co., Ltd.
- 13.16. Biovontrade SARL
- 13.17. Dabur India Ltd.
- 13.18. Phytomed Herbal Solutions
- 13.19. Medico Herbs
- 14. Research Methodology
- 15. Secondary and Primary Sources
- 16. Assumptions and Acronyms
- 17. Disclaimer
List Of Table
TABLE 1 Global Market Value (US$ Mn), 2016 to 2020
TABLE 2 Global Market Value (US$ Mn), 2021 to 2031
TABLE 3 Global Market Value (US$ Mn) and Y-o-Y, 2015 to 2031
TABLE 4 Global Immune Health Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 5 Global Immune Health Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 6 Global Immune Health Segment Market Share, By Region 2016 to 2020
TABLE 7 Global Immune Health Segment Market Share, By Region 2021 to 2031
TABLE 8 Global Immune Health Segment Y-o-Y, By Region 2015 to 2031
TABLE 9 Global Digestive Health Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 10 Global Digestive Health Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 11 Global Digestive Health Segment Market Share, By Region 2016 to 2020
TABLE 12 Global Digestive Health Segment Market Share, By Region 2021 to 2031
TABLE 13 Global Digestive Health Segment Y-o-Y, By Region 2015 to 2031
TABLE 14 Global Heart Health Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 15 Global Heart Health Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 16 Global Heart Health Segment Market Share, By Region 2016 to 2020
TABLE 17 Global Heart Health Segment Market Share, By Region 2021 to 2031
TABLE 18 Global Heart Health Segment Y-o-Y, By Region 2015 to 2031
TABLE 19 Global Nutrition Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 20 Global Nutrition Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 21 Global Nutrition Segment Market Share, By Region 2016 to 2020
TABLE 22 Global Nutrition Segment Market Share, By Region 2021 to 2031
TABLE 23 Global Nutrition Segment Y-o-Y, By Region 2015 to 2031
TABLE 24 Global Bone & Joint Health Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 25 Global Bone & Joint Health Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 26 Global Bone & Joint Health Segment Market Share, By Region 2016 to 2020
TABLE 27 Global Bone & Joint Health Segment Market Share, By Region 2021 to 2031
TABLE 28 Global Bone & Joint Health Segment Y-o-Y, By Region 2015 to 2031
TABLE 29 Global General Well being Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 30 Global General Well being Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 31 Global General Well being Segment Market Share, By Region 2016 to 2020
TABLE 32 Global General Well being Segment Market Share, By Region 2021 to 2031
TABLE 33 Global General Well being Segment Y-o-Y, By Region 2015 to 2031
TABLE 34 Global Weight Loss Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 35 Global Weight Loss Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 36 Global Weight Loss Segment Market Share, By Region 2016 to 2020
TABLE 37 Global Weight Loss Segment Market Share, By Region 2021 to 2031
TABLE 38 Global Weight Loss Segment Y-o-Y, By Region 2015 to 2031
TABLE 39 Global Other Functions Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 40 Global Other Functions Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 41 Global Other Functions Segment Market Share, By Region 2016 to 2020
TABLE 42 Global Other Functions Segment Market Share, By Region 2021 to 2031
TABLE 43 Global Other Functions Segment Y-o-Y, By Region 2015 to 2031
TABLE 44 Global Pharmacy Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 45 Global Pharmacy Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 46 Global Pharmacy Segment Market Share, By Region 2016 to 2020
TABLE 47 Global Pharmacy Segment Market Share, By Region 2021 to 2031
TABLE 48 Global Pharmacy Segment Y-o-Y, By Region 2015 to 2031
TABLE 49 Global Drug Store Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 50 Global Drug Store Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 51 Global Drug Store Segment Market Share, By Region 2016 to 2020
TABLE 52 Global Drug Store Segment Market Share, By Region 2021 to 2031
TABLE 53 Global Drug Store Segment Y-o-Y, By Region 2015 to 2031
TABLE 54 Global Modern Trade Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 55 Global Modern Trade Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 56 Global Modern Trade Segment Market Share, By Region 2016 to 2020
TABLE 57 Global Modern Trade Segment Market Share, By Region 2021 to 2031
TABLE 58 Global Modern Trade Segment Y-o-Y, By Region 2015 to 2031
TABLE 59 Global Online Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 60 Global Online Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 61 Global Online Segment Market Share, By Region 2016 to 2020
TABLE 62 Global Online Segment Market Share, By Region 2021 to 2031
TABLE 63 Global Online Segment Y-o-Y, By Region 2015 to 2031
TABLE 64 Global Other OTC Format Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 65 Global Other OTC Format Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 66 Global Other OTC Format Segment Market Share, By Region 2016 to 2020
TABLE 67 Global Other OTC Format Segment Market Share, By Region 2021 to 2031
TABLE 68 Global Other OTC Format Segment Y-o-Y, By Region 2015 to 2031
TABLE 69 Global Liquid Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 70 Global Liquid Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 71 Global Liquid Segment Market Share, By Region 2016 to 2020
TABLE 72 Global Liquid Segment Market Share, By Region 2021 to 2031
TABLE 73 Global Liquid Segment Y-o-Y, By Region 2015 to 2031
TABLE 74 Global Capsule Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 75 Global Capsule Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 76 Global Capsule Segment Market Share, By Region 2016 to 2020
TABLE 77 Global Capsule Segment Market Share, By Region 2021 to 2031
TABLE 78 Global Capsule Segment Y-o-Y, By Region 2015 to 2031
TABLE 79 Global Tablet Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 80 Global Tablet Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 81 Global Tablet Segment Market Share, By Region 2016 to 2020
TABLE 82 Global Tablet Segment Market Share, By Region 2021 to 2031
TABLE 83 Global Tablet Segment Y-o-Y, By Region 2015 to 2031
TABLE 84 Global Powder Segment Value (US$ Mn), By Region 2016 to 2020
TABLE 85 Global Powder Segment Value (US$ Mn), By Region 2021 to 2031
TABLE 86 Global Powder Segment Market Share, By Region 2016 to 2020
TABLE 87 Global Powder Segment Market Share, By Region 2021 to 2031
TABLE 88 Global Powder Segment Y-o-Y, By Region 2015 to 2031
TABLE 89 North America Market Value (US$ Mn), By Function 2016 to 2020
TABLE 90 North America Market Value (US$ Mn), By Function 2021 to 2031
TABLE 91 North America Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 92 North America Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 93 North America Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 94 North America Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 95 Latin America Market Value (US$ Mn), By Function 2016 to 2020
TABLE 96 Latin America Market Value (US$ Mn), By Function 2021 to 2031
TABLE 97 Latin America Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 98 Latin America Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 99 Latin America Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 100 Latin America Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 101 Europe Market Value (US$ Mn), By Function 2016 to 2020
TABLE 102 Europe Market Value (US$ Mn), By Function 2021 to 2031
TABLE 103 Europe Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 104 Europe Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 105 Europe Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 106 Europe Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 107 Japan Market Value (US$ Mn), By Function 2016 to 2020
TABLE 108 Japan Market Value (US$ Mn), By Function 2021 to 2031
TABLE 109 Japan Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 110 Japan Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 111 Japan Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 112 Japan Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 113 APEJ Market Value (US$ Mn), By Function 2016 to 2020
TABLE 114 APEJ Market Value (US$ Mn), By Function 2021 to 2031
TABLE 115 APEJ Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 116 APEJ Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 117 APEJ Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 118 APEJ Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 119 MEA Market Value (US$ Mn), By Function 2016 to 2020
TABLE 120 MEA Market Value (US$ Mn), By Function 2021 to 2031
TABLE 121 MEA Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 122 MEA Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 123 MEA Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 124 MEA Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 125 US Market Value (US$ Mn), By Function 2016 to 2020
TABLE 126 US Market Value (US$ Mn), By Function 2021 to 2031
TABLE 127 US Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 128 US Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 129 US Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 130 US Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 131 Canada Market Value (US$ Mn), By Function 2016 to 2020
TABLE 132 Canada Market Value (US$ Mn), By Function 2021 to 2031
TABLE 133 Canada Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 134 Canada Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 135 Canada Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 136 Canada Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 137 Brazil Market Value (US$ Mn), By Function 2016 to 2020
TABLE 138 Brazil Market Value (US$ Mn), By Function 2021 to 2031
TABLE 139 Brazil Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 140 Brazil Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 141 Brazil Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 142 Brazil Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 143 Mexico Market Value (US$ Mn), By Function 2016 to 2020
TABLE 144 Mexico Market Value (US$ Mn), By Function 2021 to 2031
TABLE 145 Mexico Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 146 Mexico Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 147 Mexico Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 148 Mexico Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 149 Argentina Market Value (US$ Mn), By Function 2016 to 2020
TABLE 150 Argentina Market Value (US$ Mn), By Function 2021 to 2031
TABLE 151 Argentina Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 152 Argentina Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 153 Argentina Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 154 Argentina Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 155 Germany Market Value (US$ Mn), By Function 2016 to 2020
TABLE 156 Germany Market Value (US$ Mn), By Function 2021 to 2031
TABLE 157 Germany Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 158 Germany Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 159 Germany Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 160 Germany Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 161 UK Market Value (US$ Mn), By Function 2016 to 2020
TABLE 162 UK Market Value (US$ Mn), By Function 2021 to 2031
TABLE 163 UK Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 164 UK Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 165 UK Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 166 UK Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 167 France Market Value (US$ Mn), By Function 2016 to 2020
TABLE 168 France Market Value (US$ Mn), By Function 2021 to 2031
TABLE 169 France Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 170 France Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 171 France Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 172 France Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 173 Spain Market Value (US$ Mn), By Function 2016 to 2020
TABLE 174 Spain Market Value (US$ Mn), By Function 2021 to 2031
TABLE 175 Spain Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 176 Spain Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 177 Spain Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 178 Spain Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 179 Italy Market Value (US$ Mn), By Function 2016 to 2020
TABLE 180 Italy Market Value (US$ Mn), By Function 2021 to 2031
TABLE 181 Italy Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 182 Italy Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 183 Italy Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 184 Italy Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 185 Nordic Market Value (US$ Mn), By Function 2016 to 2020
TABLE 186 Nordic Market Value (US$ Mn), By Function 2021 to 2031
TABLE 187 Nordic Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 188 Nordic Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 189 Nordic Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 190 Nordic Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 191 Japan Market Value (US$ Mn), By Function 2016 to 2020
TABLE 192 Japan Market Value (US$ Mn), By Function 2021 to 2031
TABLE 193 Japan Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 194 Japan Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 195 Japan Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 196 Japan Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 197 China Market Value (US$ Mn), By Function 2016 to 2020
TABLE 198 China Market Value (US$ Mn), By Function 2021 to 2031
TABLE 199 China Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 200 China Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 201 China Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 202 China Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 203 India Market Value (US$ Mn), By Function 2016 to 2020
TABLE 204 India Market Value (US$ Mn), By Function 2021 to 2031
TABLE 205 India Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 206 India Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 207 India Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 208 India Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 209 Malaysia Market Value (US$ Mn), By Function 2016 to 2020
TABLE 210 Malaysia Market Value (US$ Mn), By Function 2021 to 2031
TABLE 211 Malaysia Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 212 Malaysia Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 213 Malaysia Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 214 Malaysia Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 215 Thailand Market Value (US$ Mn), By Function 2016 to 2020
TABLE 216 Thailand Market Value (US$ Mn), By Function 2021 to 2031
TABLE 217 Thailand Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 218 Thailand Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 219 Thailand Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 220 Thailand Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 221 Singapore Market Value (US$ Mn), By Function 2016 to 2020
TABLE 222 Singapore Market Value (US$ Mn), By Function 2021 to 2031
TABLE 223 Singapore Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 224 Singapore Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 225 Singapore Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 226 Singapore Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 227 Australia Market Value (US$ Mn), By Function 2016 to 2020
TABLE 228 Australia Market Value (US$ Mn), By Function 2021 to 2031
TABLE 229 Australia Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 230 Australia Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 231 Australia Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 232 Australia Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 233 GCC Countries Market Value (US$ Mn), By Function 2016 to 2020
TABLE 234 GCC Countries Market Value (US$ Mn), By Function 2021 to 2031
TABLE 235 GCC Countries Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 236 GCC Countries Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 237 GCC Countries Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 238 GCC Countries Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 239 South Africa Market Value (US$ Mn), By Function 2016 to 2020
TABLE 240 South Africa Market Value (US$ Mn), By Function 2021 to 2031
TABLE 241 South Africa Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 242 South Africa Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 243 South Africa Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 244 South Africa Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 245 Nigeria Market Value (US$ Mn), By Function 2016 to 2020
TABLE 246 Nigeria Market Value (US$ Mn), By Function 2021 to 2031
TABLE 247 Nigeria Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 248 Nigeria Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 249 Nigeria Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 250 Nigeria Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 251 Israel Market Value (US$ Mn), By Function 2016 to 2020
TABLE 252 Israel Market Value (US$ Mn), By Function 2021 to 2031
TABLE 253 Israel Market Value (US$ Mn), By OTC Channel 2016 to 2020
TABLE 254 Israel Market Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 255 Israel Market Value (US$ Mn), By Dosage 2016 to 2020
TABLE 256 Israel Market Value (US$ Mn), By Dosage 2021 to 2031
TABLE 257 Amway Corporation Value (US$ Mn), By Function 2021 to 2031
TABLE 258 Amway Corporation Value (US$ Mn), By OTC Channel 2021 to 2031
TABLE 259 Amway Corporation Value (US$ Mn), By Dosage 2021 to 2031
List Of Figures
FIG. 1 Global Market Value (US$ Mn), 2016 to 2020
FIG. 2 Global Market Value (US$ Mn) Forecast, 2021 to 2031
FIG. 3 Global Market Value (US$ Mn) and Y-o-Y, 2015 to 2031
FIG. 4 Global Immune Health Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 5 Global Immune Health Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 6 Global Immune Health Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 7 Global Digestive Health Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 8 Global Digestive Health Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 9 Global Digestive Health Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 10 Global Heart Health Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 11 Global Heart Health Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 12 Global Heart Health Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 13 Global Nutrition Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 14 Global Nutrition Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 15 Global Nutrition Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 16 Global Bone & Joint Health Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 17 Global Bone & Joint Health Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 18 Global Bone & Joint Health Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 19 Global General Well being Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 20 Global General Well being Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 21 Global General Well being Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 22 Global Weight Loss Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 23 Global Weight Loss Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 24 Global Weight Loss Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 25 Global Other Functions Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 26 Global Other Functions Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 27 Global Other Functions Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 28 Global Pharmacy Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 29 Global Pharmacy Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 30 Global Pharmacy Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 31 Global Drug Store Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 32 Global Drug Store Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 33 Global Drug Store Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 34 Global Modern Trade Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 35 Global Modern Trade Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 36 Global Modern Trade Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 37 Global Online Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 38 Global Online Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 39 Global Online Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 40 Global Other OTC Format Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 41 Global Other OTC Format Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 42 Global Other OTC Format Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 43 Global Liquid Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 44 Global Liquid Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 45 Global Liquid Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 46 Global Capsule Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 47 Global Capsule Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 48 Global Capsule Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 49 Global Tablet Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 50 Global Tablet Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 51 Global Tablet Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 52 Global Powder Segment Market Value (US$ Mn) By Region, 2016 to 2020
FIG. 53 Global Powder Segment Market Value (US$ Mn) By Region, 2021 to 2031
FIG. 54 Global Powder Segment Y-o-Y Growth Rate, By Region, 2015 to 2031
FIG. 55 North America Market Value (US$ Mn), By Function 2016 to 2020
FIG. 56 North America Market Value (US$ Mn), By Function 2021 to 2031
FIG. 57 North America Market Value (US$ Mn), By OTC Channel 2016 to 2020
FIG. 58 North America Market Value (US$ Mn), By OTC Channel 2021 to 2031
FIG. 59 North America Market Value (US$ Mn), By Dosage 2016 to 2020
FIG. 60 North America Market Value (US$ Mn), By Dosage 2021 to 2031
FIG. 61 Latin America Market Value (US$ Mn), By Function 2016 to 2020
FIG. 62 Latin America Market Value (US$ Mn), By Function 2021 to 2031
FIG. 63 Latin America Market Value (US$ Mn), By OTC Channel 2016 to 2020
FIG. 64 Latin America Market Value (US$ Mn), By OTC Channel 2021 to 2031
FIG. 65 Latin America Market Value (US$ Mn), By Dosage 2016 to 2020
FIG. 66 Latin America Market Value (US$ Mn), By Dosage 2021 to 2031
FIG. 67 Europe Market Value (US$ Mn), By Function 2016 to 2020
FIG. 68 Europe Market Value (US$ Mn), By Function 2021 to 2031
FIG. 69 Europe Market Value (US$ Mn), By OTC Channel 2016 to 2020
FIG. 70 Europe Market Value (US$ Mn), By OTC Channel 2021 to 2031
FIG. 71 Europe Market Value (US$ Mn), By Dosage 2016 to 2020
FIG. 72 Europe Market Value (US$ Mn), By Dosage 2021 to 2031
FIG. 73 Japan Market Value (US$ Mn), By Function 2016 to 2020
FIG. 74 Japan Market Value (US$ Mn), By Function 2021 to 2031
FIG. 75 Japan Market Value (US$ Mn), By OTC Channel 2016 to 2020
FIG. 76 Japan Market Value (US$ Mn), By OTC Channel 2021 to 2031
FIG. 77 Japan Market Value (US$ Mn), By Dosage 2016 to 2020
FIG. 78 Japan Market Value (US$ Mn), By Dosage 2021 to 2031
FIG. 79 APEJ Market Value (US$ Mn), By Function 2016 to 2020
FIG. 80 APEJ Market Value (US$ Mn), By Function 2021 to 2031
FIG. 81 APEJ Market Value (US$ Mn), By OTC Channel 2016 to 2020
FIG. 82 APEJ Market Value (US$ Mn), By OTC Channel 2021 to 2031
FIG. 83 APEJ Market Value (US$ Mn), By Dosage 2016 to 2020
FIG. 84 APEJ Market Value (US$ Mn), By Dosage 2021 to 2031
FIG. 85 MEA Market Value (US$ Mn), By Function 2016 to 2020
FIG. 86 MEA Market Value (US$ Mn), By Function 2021 to 2031
FIG. 87 MEA Market Value (US$ Mn), By OTC Channel 2016 to 2020
FIG. 88 MEA Market Value (US$ Mn), By OTC Channel 2021 to 2031
FIG. 89 MEA Market Value (US$ Mn), By Dosage 2016 to 2020
FIG. 90 MEA Market Value (US$ Mn), By Dosage 2021 to 2031
- FAQs -
What are the latest trends of OTC herbal and traditional medicines?
Increasing consumer awareness, rising popularity of organic and natural products, increasing focus on preventive healthcare, and demand for alternative to modern medicine are some of the prevalent trends in the industry.
Which top manufacturers are operating in the marketplace?
Currently, Amway Corporation, Herbalife International, The Himalayan Drug Company, Naturex SA, Blackmores Limited, Nutraceutical International Corporation, and The Nature's Bounty Co are prominent in the industry.
What revenues did sales of OTC herbal and traditional medicines bring in for 2020?
In 2020, sales revenue totaled a valuation of US$ 160 Bn.
Which region is predicted to dominate the global OTC herbal and traditional medicines market?
The APAC region is expected to dominate the market in terms of revenue as well as demand.
At what pace is the market expected to progress over the decade?
The global OTC herbal and traditional medicine industry is predicted to rise at a steady CAGR of 4%.
On the basis of function, which segment is expected to account for majority of revenue?
OTC herbal and traditional medicines for digestive health are expected to rake in majority of revenue share.
What is the predicted net worth for the OTC herbal and traditional medicine industry by 2031?
By 2031, market revenue is estimated to be around US$ 240 Bn.
OTC Herbal and Traditional Medicines Market